Why the study?
Does 31P-MRS detect abnormal muscle energy metabolism in female DMD/BMD carriers compared to controls?
Does 31P-MRS detect abnormal muscle energy metabolism in female DMD/BMD carriers compared to controls?
Female DMD/BMD carriers exhibit abnormal muscle energy metabolism, including decreased work capacity and impaired postexercise recovery, as detected by 31P-MRS.
No takes yet. Share an insight, caveat, or question.
31P-MRS detects impaired muscle energetics in female DMD/BMD carriers; leaves open its diagnostic or monitoring role pending prospective studies.
Barbiroli et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: